When Finishing Early Is Worth Seeing a Doctor About

Illustration of a stethoscope

Most men never raise this with a doctor, and for a sizeable share of them that is a genuine missed opportunity, not because there is a wonder drug, but because a specific, findable, reversible cause exists more often than people expect.

The short answer

One question decides how urgent this is: has it always been this way, or did it change? If it changed, there is a real chance of an underlying cause, erectile dysfunction, chronic prostatitis or an overactive thyroid are all documented, and all treatable. In one series, premature ejaculation affected half of men with hyperthyroidism, falling to 15% once the thyroid was corrected, with no treatment aimed at the ejaculation at all.

When it changed, it may have a cause

The question that decides urgency Has it always been this way, or did it change?
ED in men with PE 31.9% vs 11.8% of men without PE
Men with ED who also report PE As many as half
PE in men with chronic prostatitis 26% to 77% across studies
Antibiotic treatment for prostatitis Improved ejaculatory latency in 59% to 84% of cases
PE in men with hyperthyroidism Around 50%
After the thyroid was corrected Fell to 15%, with no treatment aimed at the ejaculation
Tramadol Second-line, because of dependence and serotonin syndrome risk

When should you see a doctor about finishing early?

The AUA/SMSNA guideline splits premature ejaculation into two conditions, and treats them differently from the first appointment.

Lifelong PE: present since you became sexually active. Here the guideline says additional testing is not recommended. There is no hidden cause to find, and investigating further mostly generates anxiety and bills.

Acquired PE — a latency markedly reduced from what you used to experience. Here the guideline says additional testing may be used as clinically indicated. Something changed, and it is reasonable to ask what.

If you take one thing from this page: new is worth investigating, lifelong usually is not.

What can sudden premature ejaculation be a sign of?

Cause What the data show Does treating it help?
Erectile dysfunction The most common comorbidity. One large survey found ED in 31.9% of men with PE against 11.8% of men without. As many as half of men with ED also report PE. Often. The guideline directs that comorbid ED be treated on its own terms.
Chronic prostatitis / chronic pelvic pain Reported PE rates in men with chronic prostatitis range from 26% to 77% across studies. Antibiotic treatment improved ejaculatory latency in 59% to 84% of cases, with more benefit in acquired than lifelong PE.
Hyperthyroidism PE reported in around 50% of men with an overactive thyroid. Fell to 15% once thyroid function normalised, and reverted without any treatment directed at ejaculation.
Drug and substance withdrawal Stopping SSRIs, and withdrawal from some recreational substances, are documented triggers. Usually, once the withdrawal resolves.

The erectile dysfunction link deserves a note, because the relationship runs in both directions. A man who is struggling to keep an erection may unconsciously rush to finish before he loses it, which looks exactly like premature ejaculation. Equally, a man managing early ejaculation by damping down his own arousal can end up with erection problems. Which came first genuinely changes what should be treated.

What happens at the appointment?

Less than most men fear. The guideline sets out a clinical principle that assessment consists of a medical, relationship and sexual history, together with a focused physical examination. Validated questionnaires may be used to help with diagnosis, though that is a weaker, Grade C recommendation.

For lifelong PE, that is the end of it, no bloods, no scans. For acquired PE, testing follows whatever the history points at, which in practice often means thyroid function and an assessment for prostatitis or erectile dysfunction rather than a broad panel.

There is no test for premature ejaculation itself. The diagnosis is made from what you describe.

What can a doctor prescribe?

The guideline’s first-line recommendation is a strong one, Grade B, and it covers three things: daily SSRIs, on-demand clomipramine or dapoxetine where available, and topical penile anaesthetics.

Daily SSRIs. Delayed ejaculation is a well-known side effect of this class of antidepressant, and here it is the intended effect. In the US these are prescribed off-label for this purpose, meaning the drug is approved, but not specifically for this use. That is legal, common, and not a red flag.

Topical anaesthetics. In a phase III trial across 32 centres, 300 men were randomised to a lidocaine-prilocaine spray or placebo. Geometric mean latency reached four minutes on the spray against one minute on placebo, and only 2.6% of patients reported a treatment-related adverse event. The practical consideration these trials raise is transfer. The anaesthetic does not distinguish between you and your partner, which is why timing, washing off, or a condom tends to feature in the instructions.

Dapoxetine. Worth being precise about: dapoxetine is not approved by the FDA and is not legally available in the United States. It is approved in a number of other countries. If a website is offering to ship you Priligy in the US, it is selling an unapproved drug, and you have no assurance about what is in it.

Alpha-blockers appear in the guideline for men who have failed first-line treatment, but as expert opinion only. The panel had no trial evidence to point to.

Why is tramadol second-line?

Tramadol is recommended on demand for men who have failed first-line therapy, and only as a conditional, Grade C recommendation. It works, modestly. It also deserves more caution than it usually gets.

A meta-analysis of four randomised trials covering 721 men found tramadol added a mean of 1.24 minutes of latency over placebo, with a confidence interval running from 0.52 to 1.95 minutes. Statistical heterogeneity between the trials was high, which means the studies disagreed with one another more than you would like.

Adverse events were significantly more common than with placebo or behavioural therapy, and included erectile dysfunction, nausea, constipation, drowsiness, dizziness and headache. Erectile dysfunction as a side effect of a treatment for premature ejaculation is a genuinely awkward trade.

The most important line in that review is what was not studied. The authors state that addiction problems and breathing difficulties in men taking tramadol for premature ejaculation have not been assessed in the existing evidence, and that long-term effects including addiction potential have not been evaluated. Tramadol is an opioid. An unstudied addiction risk is not the same thing as a low one.

What referral might you be offered?

The guideline recommends that clinicians consider referring men with premature ejaculation to a mental health professional with expertise in sexual health: a moderate recommendation.

This is not a polite way of saying the problem is imaginary. It reflects the finding that combining behavioural and pharmacological treatment is more effective than either alone, which is itself a moderate, Grade B recommendation. The referral is part of the treatment, not a substitute for it. More on that in breathing, focus and the performance anxiety loop.

How do you bring it up?

You do not need a script, but two pieces of information make the appointment far more productive, and both are things only you can supply.

The first is whether this is lifelong or new, and if new, roughly when it changed and what else was going on at the time. The second is whether your erections are reliable, because that single answer redirects the whole consultation.

It is also reasonable to say that you would like your thyroid checked if this is new. That is not an unusual request, and it is directly supported by the evidence above.

If you are still not sure whether what you are experiencing meets the definition at all, start here.

Common questions about seeing a doctor for premature ejaculation

When should I see a doctor about premature ejaculation?

The deciding question is whether it changed. Lifelong PE is a treatable condition in its own right. PE that developed after a period of normal function is different, because it can be a symptom of something else, and several of those things are treatable in ways that resolve the ejaculation problem without treating it directly.

Can premature ejaculation be a sign of something else?

Yes, and three causes are well documented. Erectile dysfunction is the most common comorbidity, present in 31.9 percent of men with PE against 11.8 percent without. Chronic prostatitis is reported alongside PE in 26 to 77 percent of cases. And in hyperthyroidism, PE affected around half of men and fell to 15 percent once the thyroid was corrected.

Can treating my thyroid fix premature ejaculation?

In men whose PE is driven by an overactive thyroid, apparently yes. In one series, prevalence fell from around 50 percent to 15 percent after the thyroid was treated, with no treatment directed at the ejaculation at all. That is why a new-onset problem deserves a look for an underlying cause.

Why is tramadol not first-line for PE?

It works, but it is an opioid with dependence potential, and combining it with an SSRI raises the risk of serotonin syndrome. Given that SSRIs and topical anaesthetics are both first-line with strong recommendations and much better safety profiles, tramadol sits behind them.

How do I bring this up with a doctor?

Plainly, and early in the appointment rather than at the door. A useful opening is the clinical frame: say how long it has been happening, whether it has always been this way or changed, and that it is causing distress. Those are the three things the clinician needs, and stating them directly saves the conversation that most men find hardest.

How we sourced this: every figure on this page is traced to one of the 5 named sources listed below.No product is sold here and no link is paid.Who writes this

Sources

  1. American Urological Association / Sexual Medicine Society of North America. Disorders of Ejaculation: An AUA/SMSNA Guideline, 2020, amended 2022. AUA guideline
  2. McMahon CG. The pathophysiology of acquired premature ejaculation. Translational Andrology and Urology, 2016. Translational Andrology and Urology
  3. Carson C, Wyllie M. Improved ejaculatory latency, control and sexual satisfaction when PSD502 is applied topically in men with premature ejaculation. Journal of Sexual Medicine, 2010. PubMed
  4. Martyn-St James M, Cooper K, Ren S, et al. Tramadol for premature ejaculation: a systematic review and meta-analysis. BMC Urology, 2015. BMC Urology
  5. Drugs.com. Priligy (dapoxetine) FDA approval status. Drugs.com

This article is for information only and is not medical advice. It cannot account for your individual circumstances. Talk to a doctor about your own situation, particularly before starting or stopping any prescription medication.